Prof. Dr. Rainer Fietkau

Lehrstuhl für Strahlentherapie

Corrigendum: Low Dose Radiation Therapy Induces Long-Lasting Reduction of Pain and Immune Modulations in the Peripheral Blood - Interim Analysis of the IMMO-LDRT01 Trial(Front. Immunol., (2021), 12, (740742), 10.3389/fimmu.2021.740742) (2022) Donaubauer AJ, Becker I, Weissmann T, Fröhlich B, Munoz LE, Gryc T, Denzler M, et al. Journal article, Erratum Radon Improves Clinical Response in an Animal Model of Rheumatoid Arthritis Accompanied by Increased Numbers of Peripheral Blood B Cells and Interleukin-5 Concentration (2022) Deloch L, Hehlgans S, Rückert M, Maier A, Hinrichs A, Flohr AS, Eckert D, et al. Journal article Clinical Evidence for Thermometric Parameters to Guide Hyperthermia Treatment (2022) Ademaj A, Veltsista DP, Ghadjar P, Marder D, Oberacker E, Ott O, Wust P, et al. Journal article, Review article Targeted Therapy, Chemotherapy, Immunotherapy and Novel Treatment Options for Different Subtypes of Salivary Gland Cancer (2022) Müller SK, Haderlein M, Lettmaier S, Agaimy A, Haller F, Hecht M, Fietkau R, et al. Journal article, Review article Induction chemoimmunotherapy followed by CD8+ immune cell-based patient selection for chemotherapy-free radioimmunotherapy in locally advanced head and neck cancer (2022) Hecht M, Eckstein M, Rutzner S, von der Grün J, Illmer T, Klautke G, Laban S, et al. Journal article The Prognostic Value of FoxP3+Tumour-Infiltrating Lymphocytes in Rectal Cancer Depends on Immune Phenotypes Defined by CD8+Cytotoxic T Cell Density (2022) Schnellhardt S, Hirneth J, Büttner-Herold M, Daniel C, Haderlein M, Hartmann A, Fietkau R, Distel L Journal article Risk analysis for radiotherapy at the Universitätsklinikum Erlangen (2022) Lohmann D, Lang-Welzenbach M, Feldberger L, Sommer E, Bücken S, Lotter M, Ott O, et al. Journal article Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients (2022) Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer AJ, Nimmerjahn F, et al. Journal article Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study (2022) Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, et al. Journal article Accuracy of MRI-CT registration in brain stereotactic radiotherapy: Impact of MRI acquisition setup and registration method (2022) Masitho S, Putz F, Mengling V, Reißig L, Voigt R, Bäuerle T, Janka RM, et al. Journal article